Clinical Trial Update: Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

An update on the Phase 2 study of AR-67 (DB-67) for Myelodysplastic Syndrome. The current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AR-67 (DB-67) (AR-67)

Snippet

Sponsor: Arno Therapeutics | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: UNKNOWN